INITIAL EVALUATION OF THE DIAGNOSTIC PERFORMANCE OF THE NEW URINARY BLADDER CANCER ANTIGEN TEST AS A TUMOR MARKER FOR TRANSITIONAL CELL CARCINOMA OF THE BLADDER
- 1 April 1999
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 161 (4), 1110-1115
- https://doi.org/10.1016/s0022-5347(01)61604-5
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Initial Evaluation of Cyfra 21-1 Diagnostic Performances as a Urinary Marker in Bladder Transitional Cell CarcinomaJournal of Urology, 1997
- Urinary Nuclear Matrix Protein as a Marker for Transitional Cell Carcinoma of the Urinary TractJournal of Urology, 1996
- Progress in the treatment of invasive bladder cancerCurrent Opinion in Urology, 1996
- Preventing recurrence and progression in superficial bladder cancerCurrent Opinion in Urology, 1996
- Prognostic markers in bladder cancerCurrent Opinion in Urology, 1996
- Initial Evaluation of the Bladder Tumor Antigen Test in Superficial Bladder CancerJournal of Urology, 1996
- The biochemistry of CYFRA 21—1 and other cytokeratin-testsScandinavian Journal of Clinical and Laboratory Investigation, 1995
- Study of a New Tumor Marker, CYFRA21-1, in Malignant and Nonmalignant DiseasesTumor Biology, 1994
- Biology and Management of Bladder CancerNew England Journal of Medicine, 1990
- Keratins as biochemical markers of epithelial differentiationTrends in Genetics, 1988